You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 22, 2024

Details for Patent: 6,080,756


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 6,080,756
Title: Polymorphs of the prodrug 6-N-(L-ALA-L-ALA)-trovafloxacin
Abstract:The invention relates to a monohydrate polymorph PII.M of a compound of the formula ##STR1## exhibiting the following X-ray powder diffraction pattern The invention also relates to methods of preparing the above compound, pharmaceutical compositions containing the above compound, and methods of treating bacterial infections by administering the above compound.
Inventor(s): Norris; Timothy (Gales Ferry, CT), McGarry; James J. (Ledyard, CT), Allen; Douglas J. M. (New London, CT)
Assignee: Pfizer Inc. (New York, NY)
Application Number:09/011,370
Patent Claim Types:
see list of patent claims
Compound; Process; Use; Composition;
Patent landscape, scope, and claims:

Understanding the Scope and Claims of United States Patent 6,080,756

Introduction

United States Patent 6,080,756, titled "Polymorphs of the prodrug 6-N-(L-ALA-L-ALA)-trovafloxacin," is a patent that delves into the realm of pharmaceutical compositions and methods related to a specific prodrug. Here, we will analyze the scope, claims, and the broader patent landscape surrounding this invention.

Background of the Invention

The patent focuses on polymorphs of the prodrug 6-N-(L-ALA-L-ALA)-trovafloxacin, which is used in the treatment of bacterial infections. The invention includes methods of using and pharmaceutical compositions comprising these polymorphs[4].

Scope of the Invention

The scope of the invention is defined by the patent claims, which are the legal definition of the inventor's protectable invention. Here, the claims encompass various aspects of the polymorphs, including their composition, methods of preparation, and methods of use.

Claims Analysis

Independent Claims

Independent claims in a patent are standalone claims that define the invention without referencing other claims. For US Patent 6,080,756, the independent claims would typically include:

  • Claims for the composition of matter, such as the specific polymorphs of the prodrug.
  • Claims for methods of making these polymorphs.
  • Claims for methods of using these polymorphs in pharmaceutical treatments.

For example, an independent claim might read:

"A pharmaceutical composition comprising a polymorph of 6-N-(L-ALA-L-ALA)-trovafloxacin, characterized by a specific X-ray diffraction pattern."

Dependent Claims

Dependent claims further limit the scope of the independent claims by adding additional elements or steps. These claims incorporate by reference all the limitations of the claim from which they depend. For instance:

"The pharmaceutical composition of claim 1, wherein the polymorph is used for the treatment of bacterial infections."

Patent Claims Structure

Patent claims must be written in a specific format. Each claim must start with a capital letter and end with a period. The claims must be presented on a separate sheet following the detailed description of the invention. Independent claims are self-contained, while dependent claims refer back to and further limit another claim[2].

Patent Landscape Analysis

Technological Domain

Patent landscape analysis, also known as patent mapping, helps in understanding the entire landscape of a technological domain. For US Patent 6,080,756, this analysis would involve:

  • Identifying other patents related to polymorphs of pharmaceutical compounds.
  • Analyzing the legal status of these patents (alive, pending, lapsed, revoked, or expired).
  • Determining expected expiry dates to understand the competitive landscape.
  • Identifying trends, market developments, and potential business risks and opportunities[3].

Competitor Analysis

A thorough patent landscape analysis would reveal competitors in the field of pharmaceutical polymorphs. This includes identifying companies and research institutions that have filed similar patents, their filing dates, and the countries where these patents are filed. This information is crucial for strategic decision-making and minimizing business risks.

Legal Status and Expiry Dates

The legal status of US Patent 6,080,756 is listed as "Expired - Fee Related," indicating that the patent has expired due to non-payment of maintenance fees. Understanding the legal status and expiry dates of related patents is essential for planning future research and development, as well as for licensing and litigation strategies[4].

Business and Technical Insights

Patent landscape reports provide valuable insights into the business and technical aspects of the invention. For example:

  • Market Trends: Identifying trends in the development of pharmaceutical polymorphs can help in understanding market demand and potential areas for innovation.
  • Mergers and Acquisitions: Analyzing mergers and acquisitions in the pharmaceutical industry can reveal strategic moves by competitors and potential opportunities for collaboration or acquisition.
  • Litigation and Opposition: Understanding litigation and opposition activities related to similar patents can help in anticipating and mitigating legal risks[3].

Cost and Timeline of Patenting Process

The process of obtaining a patent, including the one for US Patent 6,080,756, involves significant costs and time. The average U.S. utility patent application takes about three years to be resolved, though this can be longer for biotech and computer fields. The costs include filing fees, patent prosecution fees, and maintenance fees to keep the patent enforceable for its 20-year term[5].

Key Takeaways

  • Claims Definition: The patent claims define the exclusive right granted to the patent applicant and are the most critical part of the patent application.
  • Patent Landscape: Understanding the broader patent landscape helps in identifying competitors, market trends, and potential business risks and opportunities.
  • Legal Status: The legal status and expiry dates of patents are crucial for strategic planning and decision-making.
  • Business Insights: Patent landscape analysis provides valuable business and technical insights that can guide innovation and market strategy.

Frequently Asked Questions (FAQs)

Q: What is the primary focus of United States Patent 6,080,756? A: The primary focus is on polymorphs of the prodrug 6-N-(L-ALA-L-ALA)-trovafloxacin and their use in pharmaceutical treatments.

Q: What is the significance of independent claims in a patent? A: Independent claims are standalone claims that define the invention without referencing other claims and are essential for understanding the scope of the patent.

Q: How does patent landscape analysis help in understanding the technological domain? A: Patent landscape analysis helps in identifying competitors, market trends, legal status of patents, and potential business risks and opportunities.

Q: Why is the legal status of a patent important? A: The legal status (alive, pending, lapsed, revoked, or expired) is crucial for understanding the competitive landscape and planning future research and development.

Q: What are the typical costs associated with obtaining a U.S. patent? A: The costs include filing fees ($2,000 to $3,500 for provisional, $8,000 to $12,000 for regular applications), patent prosecution fees ($10,000 to $20,000), and maintenance fees to keep the patent enforceable.

Cited Sources:

  1. US6080756A - Polymorphs of the prodrug 6-N-(L-ALA-L-ALA)-trovafloxacin - Google Patents
  2. Understanding Patent Claims - IPWatchdog.com
  3. Navigating Technological Domains with Patent Landscape Analysis - Sagacious Research
  4. Legal Protections - Office of Technology Transfer, Penn State

By understanding the scope, claims, and the broader patent landscape of US Patent 6,080,756, businesses and researchers can better navigate the complex world of pharmaceutical innovations and make informed decisions to drive market domination.

More… ↓

⤷  Subscribe


Drugs Protected by US Patent 6,080,756

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

Foreign Priority and PCT Information for Patent: 6,080,756

PCT Information
PCT FiledJuly 05, 1996PCT Application Number:PCT/IB96/00653
PCT Publication Date:March 06, 1997PCT Publication Number: WO97/08191

International Family Members for US Patent 6,080,756

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
African Regional IP Organization (ARIPO) 639 ⤷  Subscribe
African Regional IP Organization (ARIPO) 9600854 ⤷  Subscribe
Argentina 004507 ⤷  Subscribe
Austria 208790 ⤷  Subscribe
Australia 6135196 ⤷  Subscribe
Australia 696414 ⤷  Subscribe
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.